Patients News | pharmaphorum

News

ChatGPT can cut review times for clinical trial eligibility

ChatGPT can't replace humans when it comes to checking patient eligibility to take part in clinical trials, but it can save time and money.

News

Tech giants back unified health data-sharing platform in US

The Trump administration wants to build an interoperable digital health platform for handling patient records, medical systems, and apps.

News

Google wearable AI can 'learn the language of our bodies'

Google unveils a new family of sensor–language foundation models that could underpin a new generation of smarter health wearables.

News

Tidmarsh to stand in for Prasad's role at CBER

Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

News

FDA gives the go-ahead to restart Elevidys shipments

Sarepta has restarted distribution of its Duchenne muscular dystrophy gene therapy Elevidys, but only for patients who can walk.

News

RFK Jr formally backs thimerosal ban in US vaccines

HHS Secretary Robert F Kennedy Jr has formally signed off on a recommendation to remove thimerosal from all flu vaccines in the US

ChatGPT can cut review times for clinical trial eligibility

Tech giants back unified health data-sharing platform in US

Google wearable AI can 'learn the language of our bodies'

Tidmarsh to stand in for Prasad's role at CBER

FDA gives the go-ahead to restart Elevidys shipments

RFK Jr formally backs thimerosal ban in US vaccines

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks